Receiving Drugs Containing Selenium Does Not Reduce The Risk Of Lung Cancer

Receiving Drugs Containing Selenium Does Not Reduce The Risk Of Lung Cancer.
Taking the favoured mineral extend selenium doesn't powder the probability of lung cancer recurrence, a new study reveals. Lead originator Dr Daniel D Karp, a professor in the concern of thoracic head and neck medical oncology at the University of Texas MD Anderson Cancer Center, is scheduled to backsheesh the decision Saturday at the American Society of Clinical Oncology annual meeting, in Chicago view site. "Several epidemiological and unrefined studies have long-suggested a tie-in between deficiency of selenium and cancer development," said Karp in a advice release.

So "Interest and research escalated in the tardy 1990s after a skin cancer and selenium study, published in 1996, found no help against the skin cancer, but did suggest an approximate 30 percent reduction of prostate and lung cancers. Our lung cancer examination and another greater study for the prevention of prostate cancer evolved from that finding".

But the novel study found that among more than 1,500 condition 1 (early) non-small cell lung cancer patients who had survived their approve bout with the disease, selenium offered no barrier against recurrence or the onset of a new cancer or other primary cancer. The patients were tracked from 2000 to 2009, after all had undergone surgery to undo their initial tumors and remained cancer-free for a least of six months post-treatment.

Half the patients were placed on a regimen of 200 micrograms of selenium, while the other half took a placebo. Those in the placebo bring had better survival rates five years later than those taking the appurtenance - an attention that led the enquiry team to halt the study earlier than planned.

While 78 percent taking the placebo stayed bustling over that time frame, the fee was just 72 percent among the selenium group. And while 1,4 percent of the placebo organize developed a second primary tumor within a year, that device rose to 1,9 percent to each the selenium group, the researchers said breast size. Some benefit of selenium was observed in a matter-of-fact group of patients who had never smoked, but the study authors said the aggregation was too small to render the finding meaningful.